Journey Medical Corporation DERM Business Segments — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Journey Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Journey Medical Corporation's business segments — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Journey Medical Corporation's business segments — revenue?
- Journey Medical Corporation (DERM) reported business segments — revenue of $15.96M in Q1 2026.
- How has Journey Medical Corporation's business segments — revenue changed year-over-year?
- Journey Medical Corporation's business segments — revenue increased by 21.5% year-over-year, from $13.14M to $15.96M.
- What does business segments — revenue mean?
- Represents the total gross income generated from the sale of dermatological pharmaceutical products and authorized generics. This metric serves as the primary indicator of market demand and commercial success for the company's skin-care portfolio.